tradingkey.logo

Inogen Inc

INGN
View Detailed Chart
7.030USD
-0.360-4.87%
Close 11/06, 16:00ETQuotes delayed by 15 min
190.09MMarket Cap
LossP/E TTM

Inogen Inc

7.030
-0.360-4.87%
Intraday
1m
30m
1h
D
W
M
D

Today

-4.87%

5 Days

-13.95%

1 Month

-16.61%

6 Months

-0.57%

Year to Date

-23.34%

1 Year

-26.54%

View Detailed Chart

TradingKey Stock Score of Inogen Inc

Currency: USD Updated: 2025-11-06

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Inogen Inc's Score

Industry at a Glance

Industry Ranking
58 / 210
Overall Ranking
147 / 4615
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 2 analysts
Buy
Current Rating
13.000
Target Price
+75.91%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Inogen Inc Highlights

StrengthsRisks
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.
Undervalued
The company’s latest PE is -6.66, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 20.07M shares, decreasing 18.64% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 521.73K shares of this stock.

Inogen Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Inogen Inc Info

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.
Ticker SymbolINGN
CompanyInogen Inc
CEOMr. Kevin R. M. Smith
Websitehttps://www.inogen.com/
KeyAI